Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases
- PMID: 21541231
- PMCID: PMC3085394
- DOI: 10.1155/2011/406473
Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases
Abstract
Conquering cardiovascular diseases is one of the most important problems in human health. To overcome cardiovascular diseases, animal models have played important roles. Although the prevalence of genetically modified animals, particularly mice and rats, has contributed greatly to biomedical research, not all human diseases can be investigated in this way. In the study of cardiovascular diseases, mice and rats are inappropriate because of marked differences in lipoprotein metabolism, pathophysiological findings of atherosclerosis, and cardiac function. On the other hand, since lipoprotein metabolism and atherosclerotic lesions in rabbits closely resemble those in humans, several useful animal models for these diseases have been developed in rabbits. One of the most famous of these is the Watanabe heritable hyperlipidemic (WHHL) rabbit, which develops hypercholesterolemia and atherosclerosis spontaneously due to genetic and functional deficiencies of the low-density lipoprotein (LDL) receptor. The WHHL rabbit has been improved to develop myocardial infarction, and the new strain was designated the myocardial infarction-prone WHHL (WHHLMI) rabbit. This review summarizes the importance of selecting animal species for translational research in biomedical science, the development of WHHL and WHHLMI rabbits, their application to the development of hypocholesterolemic and/or antiatherosclerotic drugs, and future prospects regarding WHHL and WHHLMI rabbits.
Figures



Similar articles
-
The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (I) - Contribution to the Elucidation of the Pathophysiology of Human Hypercholesterolemia and Coronary Heart Disease.J Atheroscler Thromb. 2020 Feb 1;27(2):105-118. doi: 10.5551/jat.RV17038-1. Epub 2019 Nov 21. J Atheroscler Thromb. 2020. PMID: 31748469 Free PMC article. Review.
-
The History of the WHHL Rabbit, an Animal Model of Familial Hypercholesterolemia (II) - Contribution to the Development and Validation of the Therapeutics for Hypercholesterolemia and Atherosclerosis.J Atheroscler Thromb. 2020 Feb 1;27(2):119-131. doi: 10.5551/jat.RV17038-2. Epub 2019 Nov 21. J Atheroscler Thromb. 2020. PMID: 31748470 Free PMC article.
-
The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: a tribute to the late Dr. Yoshio Watanabe.Atherosclerosis. 2009 Nov;207(1):1-7. doi: 10.1016/j.atherosclerosis.2009.03.024. Epub 2009 Apr 1. Atherosclerosis. 2009. PMID: 19389675 Review.
-
Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia.Proc Natl Acad Sci U S A. 1982 May;79(10):3305-9. doi: 10.1073/pnas.79.10.3305. Proc Natl Acad Sci U S A. 1982. PMID: 6285345 Free PMC article.
-
Genomic and Transcriptomic Analysis of Hypercholesterolemic Rabbits: Progress and Perspectives.Int J Mol Sci. 2018 Nov 8;19(11):3512. doi: 10.3390/ijms19113512. Int J Mol Sci. 2018. PMID: 30413026 Free PMC article. Review.
Cited by
-
Bisphenol A exposure enhances atherosclerosis in WHHL rabbits.PLoS One. 2014 Oct 21;9(10):e110977. doi: 10.1371/journal.pone.0110977. eCollection 2014. PLoS One. 2014. PMID: 25333893 Free PMC article.
-
Long-term high-fructose high-fat diet feeding elicits insulin resistance, exacerbates dyslipidemia and induces gut microbiota dysbiosis in WHHL rabbits.PLoS One. 2022 Feb 23;17(2):e0264215. doi: 10.1371/journal.pone.0264215. eCollection 2022. PLoS One. 2022. PMID: 35196347 Free PMC article.
-
Thermal intravascular photoacoustic imaging.Biomed Opt Express. 2011 Nov 1;2(11):3072-8. doi: 10.1364/BOE.2.003072. Epub 2011 Oct 13. Biomed Opt Express. 2011. PMID: 22076268 Free PMC article.
-
The effects of jiang-zhi-ning and its main components on cholesterol metabolism.Evid Based Complement Alternat Med. 2012;2012:928234. doi: 10.1155/2012/928234. Epub 2012 May 9. Evid Based Complement Alternat Med. 2012. PMID: 22649479 Free PMC article.
-
Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.Pharmacol Ther. 2015 Feb;146:104-19. doi: 10.1016/j.pharmthera.2014.09.009. Epub 2014 Sep 30. Pharmacol Ther. 2015. PMID: 25277507 Free PMC article. Review.
References
-
- World Health Organization. The World Health Report 2002—Reducing Risks, Promoting Healthy Life: Statistical Annex. Geneva, Switzerland: World Health Organization; 2002. - PubMed
-
- Teramoto T, Sasaki J, Ueshima H, et al. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. Journal of Atherosclerosis and Thrombosis. 2007;14(2):45–50. - PubMed
-
- Yusuf S, Anand S. Cost of prevention: the case of lipid lowering. Circulation. 1996;93(10):1774–1776. - PubMed
-
- Endo A, Kuroda M, Tsujita Y. ML 236A, ML 236B, and ML 236C, new inhibitors of cholesterogenesis produced by Penicillium citrinum. Journal of Antibiotics. 1976;29(12):1346–1348. - PubMed
-
- Tsujita Y, Kuroda M, Shimada Y. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochimica et Biophysica Acta. 1986;877(1):50–60. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical